Applied Genetic Technologies Corp
AGTCDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001273636
Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Applied Genetic Technologies Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Applied Genetic Technologies Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hurwitz Edward | Director | 0Indirect | Dec 1, 2022 | 0 |
| Vanlent Anne | Director | – | Dec 1, 2022 | 0 |
| Lieber Jonathan I | Chief Financial Officer | – | Dec 1, 2022 | 0 |
| Potter Stephen W | Chief Business Officer | 0 | Dec 1, 2022 | 0 |
| Koenig Scott | Director | 0 | Dec 1, 2022 | 0 |
| Aliski William | Director | 0 | Dec 1, 2022 | 0 |
| Washer Susan B. | President and CEO | 0 | Dec 1, 2022 | 0 |
| Rosen James | Director | 0 | Dec 1, 2022 | 0 |
| Robinson James A. Jr. | Director | – | Dec 1, 2022 | 0 |
| Reynolds Gerald Anthony | Chief Accounting Officer | 0 | Dec 1, 2022 | 0 |
| Hashad Yehia | Director | – | Dec 1, 2022 | 0 |
| Schneider Susan | Chief Medical Officer | – | Dec 1, 2022 | 0 |
| Scaria Abraham | Chief Scientific Officer | – | Dec 1, 2022 | 0 |
| DOyley-Gay Hope | General Counsel | – | Dec 1, 2022 | 0 |
| Magovcevic-Liebisch Ivana | Director | – | Dec 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 (view filing) | Jul 1 | Same day | Potter Stephen WChief Business Officer | SSale | −8.07K | $0.77 | −$6.21K | −12.6%55.9K after | |
| May 31, 2022 (view filing) | May 27 | 4 days | Reynolds Gerald AnthonyChief Accounting Officer | SSale | −3.99K | $0.85 | −$3.39K | −16.0%21.0K after | |
| Feb 22, 2022 (view filing)9:34 PM ET | Feb 18 | 4 days | Washer Susan B.President and CEO | SSale | −9.95K | $2.18 | −$21.7K | −6.5%143.0K after |